Joseph Pitts actually said...

Under the proposed Senate framework, FDA would be barred from requiring compounding manufacturers to submit NDAs and ANDAs pre-inspection and labeling requirements before these drugs reach patients.

Context

Pitts highlights concerns about FDA's regulatory limitations on compounding manufacturers.

07/15/2013

https://congress.gov...

More Joseph Pitts Quotes

over 120,000 of my constituents who currently don't have health insurance will be able to get that insurance without fear of discrimination ...
7/31/2013
Let's put pen to paper and make sure the bad actors are not able to hide from clear enforcement authority.
7/15/2013
Considering that they are more similar in function to manufacturers, should they be regulated within the manufacturing framework?
7/15/2013
The chair thanks the gentleman and now recognizes the gentleman from Virginia, Mr. Griffith, for 5 minutes for questions.
7/15/2013

View All Joseph Pitts Quotes